Loading...
The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer
Recently, an anti-angiogenic strategy to treat gastric cancer (GC) has been successful with the use of ramucirumab. The comprehensive network of VEGF, soluble VEGF receptor-2 (sVEGFR2) and cytokines and other angiogenic factors (CAF) in GC has not been reported. We aimed to reveal the CAF signature...
Saved in:
| Published in: | Am J Cancer Res |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
e-Century Publishing Corporation
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4697684/ https://ncbi.nlm.nih.gov/pubmed/26807318 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|